Cabozantinib beim fortgeschrittenen hepatozellulären Karzinom; Cabozantinib for advanced hepatocellular carcinoma;Alakus, Hakan; Kütting, Fabian; Bruns, Christiane · Der Onkologe · 2018

Pharmacokinetic (PK) drug interaction studies of cabozantinib: Effect of CYP3A inducer rifampin and inhibitor ketoconazole on cabozantinib plasma PK and effect of cabozantinib on CYP2C8 probe substrate rosiglitazone plasma PKNguyen, Linh; Holland, Jaymes; Miles, Dale; Engel, Caroline; Benrimoh, Natacha; O'Reilly, Terry; Lacy, Steven · The Journal of Clinical Pharmacology · 2015

CaboACC: Cabozantinib beim fortgeschrittenen Nebennierenkarzinom nach Versagen der Standardtherapie; CaboACC: Cabozantinib in advanced adrenocortical carcinoma after failure of standard therapy;Kroiß, Matthias; Goebeler, Maria-Elisabeth; Röser, Christoph; Zimmermann, Sebastian; Landwehr, Laura; Scherf-Clavel, Oliver; Malzahn, Uwe; Kurlbaum, Max; Faßnacht, Martin · Forum · 2019

CT-707, a novel FAK inhibitor, synergizes with Cabozantinib to suppress hepatocellular carcinoma by blocking Cabozantinib-induced FAK activationWang, D.-D.; Chen, Y.; Chen, Z.-b.; Yan, F.-J.; Dai, X.-Y.; Ying, M.-d.; Cao, J.; Ma, J.; Luo, P.; Han, Y.-X.; Peng, Y.; Sun, Y.; Zhang, H.; He, Q.-j.; Yang, B.; Zhu, H. · Molecular Cancer Therapeutics · 2016

CabozantinibKerkhoff, Andrew D; Gupta, Ankur; Samandari, Taraz; Lawn, Stephen D · Reactions Weekly · 2013

CabozantinibReactions Weekly · 2013

Cabozantinib/zoledronic acidReactions Weekly · 2014

CabozantinibReactions Weekly · 2014

Biperiden/trihexyphenidylReactions Weekly · 1995

NitrendipineReactions Weekly · 2003

ScopolamineReactions Weekly · 2007

ScopolamineReactions Weekly · 2012

ScopolamineReactions Weekly · 2009

Centella asiaticaReactions Weekly · 2011

Daunorubicin/mitoxantroneReactions Weekly · 2007

AnthracyclinesReactions Weekly · 1991